Wednesday 11 December, 2019
Edition: English (US)
Tag Archives: OTCMKTS:GBLX

GB Sciences Inc (OTCMKTS:GBLX) says it will unveil some new medical cannabis products in a matter of months. This business guru believes it is good to educate Louisiana pharmacists and physicians about the products. The company’s subsidiary GB...

By Steven Russell on Aug 20th, 2019

GB Sciences Inc (OTCMKTS:GBLX) announced on Wednesday that its subsidiary GBS Global Biopharma, Inc. filed a patent application for its chronic pain formulations made using cannabis extracts. The newly filed patent covers the proprietary...

By Steven Russell on Jul 19th, 2019

In the last trading session, the stock price of GB Sciences Inc (OTCMKTS:GBLX) gained more than 22% to close the day at $0.8003. Among other updates, back in the month of October, the company reported that it has finalized a production deal...

By David Rees on Jan 2nd, 2018
Growblox Sciences Inc

Growblox Sciences Inc (OTCMKTS:GBLX) has recently filed multiple patent applications for the innovations developed by Growblox Life Sciences, LLC. Patent Applications The company’s patent applications include complex-cannabinoid (CBD)-containing...

By Emily Gibson on Dec 12th, 2016

Growblox Sciences Inc (OTCMKTS:GBLX) announced the submission of the first of several patent filings for life science inventions by its subsidiary firm, Growblox Life Sciences, LLC.  The existing provisional patent application comprises complex-cannabinoid-containing...

By Emily Gibson on Dec 9th, 2016